MSU
LLY icon

Maple Securities USA’s Eli Lilly LLY Stock Holding History

Maple Securities USA’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-5,780
Closed -$420K – 273
2015
Q1 		$420K Buy
+5,780
New +$411K 0.04% 129
2014
Q1 		– Sell
-6,416
Closed -$327K – 279
2013
Q4 		$327K Sell
6,416
-104,413
-94% -$5.23M 0.02% 244
2013
Q3 		$5.58M Buy
110,829
+19,620
+22% +$1.03M 0.44% 39
2013
Q2 		$4.48M Buy
+91,209
New +$4.96M 0.41% 49

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Maple Securities USA's LLY Position: Q2 2015 in Review

Maple Securities USA sold out of Eli Lilly (LLY) in Q2 2015, closing a stake of 5,780 shares — an estimated $420K sold.

Maple Securities USA first reported a position in LLY in Q2 2013 and held it in 4 quarters. The position peaked at $5.58M in Q3 2013. 1,137 funds tracked by Wall St. Rank hold LLY as of Q2 2015.

  • Maple Securities USA reported no remaining Eli Lilly position as of Q2 2015 after selling out during the quarter.
  • Maple Securities USA sold 5,780 Eli Lilly shares in Q2 2015, an estimated $420K.
  • Maple Securities USA first reported a position in Eli Lilly in Q2 2013 and held it in 4 quarters.
  • Maple Securities USA's Eli Lilly position peaked at $5.58M in Q3 2013.
  • 1,137 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2015.

Based on Maple Securities USA's 13F filing for Q2 2015, filed 24 Jul 2015.